DTIL - Precision Biosciences Inc
IEX Last Trade
10.82
0.270 2.495%
Share volume: 63,847
Last Updated: Fri 30 Aug 2024 09:59:50 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$10.55
0.27
2.56%
View ratios
| Fiscal Date | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | 2024-06-30 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | |
| Report Date | 2022-11-08 | 2023-03-09 | 2023-05-09 | 2023-08-04 | 2023-11-07 | 2024-03-27 | 2024-05-13 | 2024-08-01 | |
| Total revenue | 7.363 M | 10.598 M | 8.780 M | 19.789 M | 13.120 M | 7.038 M | 17.584 M | 49.898 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Gross profit | 7.363 M | 10.598 M | 8.780 M | 19.789 M | 13.120 M | 7.038 M | 17.584 M | 49.898 M | |
| 43.94% | -17.15% | 125.39% | -33.70% | -46.36% | 149.84% | 183.77% | |||
| Operating expenses | 30.293 M | 31.087 M | 33.244 M | 31.776 M | 25.483 M | 1.960 M | 21.771 M | 25.752 M | |
| Selling general and admin | 10.334 M | 10.015 M | 11.086 M | 9.830 M | 9.633 M | 8.539 M | 8.428 M | 8.527 M | |
| Research and development | 19.959 M | 21.072 M | 22.158 M | 21.946 M | 15.850 M | -6.579 M | 13.343 M | 17.225 M | |
| Total expenses | 32.076 M | 28.483 M | 34.585 M | 31.776 M | 26.833 M | 2.831 M | 21.771 M | 25.752 M | |
| -11.20% | 21.42% | -8.12% | -15.56% | -89.45% | 669.02% | 18.29% | |||
| Operating income | -24.713 M | -17.885 M | -25.805 M | -11.987 M | -13.713 M | 4.207 M | -4.187 M | 24.146 M | |
| Ebit | -24.713 M | -17.885 M | -25.805 M | -11.987 M | -13.713 M | 4.207 M | -4.187 M | 24.146 M | |
| Pretax income | -23.946 M | -28.488 M | -25.060 M | -11.891 M | -12.110 M | 6.534 M | 8.588 M | 32.749 M | |
| 18.97% | -12.03% | -52.55% | 1.84% | -153.96% | 31.44% | 281.33% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | -23.946 M | -28.488 M | -25.060 M | -11.891 M | -8.079 M | -16.289 M | 8.588 M | 32.749 M | |
| -18.97% | 12.03% | 52.55% | 32.06% | -101.62% | 152.72% | 281.33% | |||
| Net income | -23.946 M | -28.488 M | -25.060 M | -11.891 M | -8.079 M | -16.289 M | 8.588 M | 32.749 M | |
| -18.97% | 12.03% | 52.55% | 32.06% | -101.62% | 152.72% | 281.33% |